321 related articles for article (PubMed ID: 21883694)
1. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer.
Tsuchida A; Ohno S; Wu W; Borjigin N; Fujita K; Aoki T; Ueda S; Takanashi M; Kuroda M
Cancer Sci; 2011 Dec; 102(12):2264-71. PubMed ID: 21883694
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development.
Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M
Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884
[TBL] [Abstract][Full Text] [Related]
3. The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.
Ottman R; Levy J; Grizzle WE; Chakrabarti R
Oncotarget; 2016 Nov; 7(45):73739-73753. PubMed ID: 27650539
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-17-92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblast apoptosis.
Guo L; Xu J; Qi J; Zhang L; Wang J; Liang J; Qian N; Zhou H; Wei L; Deng L
J Cell Sci; 2013 Feb; 126(Pt 4):978-88. PubMed ID: 23264746
[TBL] [Abstract][Full Text] [Related]
5. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer.
Zhang H; Zuo Z; Lu X; Wang L; Wang H; Zhu Z
Oncol Rep; 2012 Feb; 27(2):594-8. PubMed ID: 22076535
[TBL] [Abstract][Full Text] [Related]
6. miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11.
Niu H; Wang K; Zhang A; Yang S; Song Z; Wang W; Qian C; Li X; Zhu Y; Wang Y
Oncol Rep; 2012 Nov; 28(5):1771-7. PubMed ID: 22895567
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
Pekow J; Meckel K; Dougherty U; Butun F; Mustafi R; Lim J; Crofton C; Chen X; Joseph L; Bissonnette M
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(3):G179-87. PubMed ID: 25477374
[TBL] [Abstract][Full Text] [Related]
8. MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim.
Lv XB; Zhang X; Deng L; Jiang L; Meng W; Lu Z; Wang X
Cell Biol Int; 2014 Apr; 38(4):435-43. PubMed ID: 24375836
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
10. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
Hu S; Liu L; Chang EB; Wang JY; Raufman JP
Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
[TBL] [Abstract][Full Text] [Related]
11. MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells.
Wu Q; Yang Z; Wang F; Hu S; Yang L; Shi Y; Fan D
J Cell Sci; 2013 Sep; 126(Pt 18):4220-9. PubMed ID: 23868977
[TBL] [Abstract][Full Text] [Related]
12. miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression.
Chen Z; Chen LY; Dai HY; Wang P; Gao S; Wang K
J Cell Biochem; 2012 Oct; 113(10):3229-35. PubMed ID: 22628193
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.
Nishida N; Yamashita S; Mimori K; Sudo T; Tanaka F; Shibata K; Yamamoto H; Ishii H; Doki Y; Mori M
Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.
de Groen FL; Timmer LM; Menezes RX; Diosdado B; Hooijberg E; Meijer GA; Steenbergen RD; Carvalho B
PLoS One; 2015; 10(7):e0132495. PubMed ID: 26148070
[TBL] [Abstract][Full Text] [Related]
16. miR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells.
Humphreys KJ; McKinnon RA; Michael MZ
PLoS One; 2014; 9(11):e112288. PubMed ID: 25379703
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
18. microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution.
Knudsen KN; Nielsen BS; Lindebjerg J; Hansen TF; Holst R; Sørensen FB
PLoS One; 2015; 10(10):e0140503. PubMed ID: 26465597
[TBL] [Abstract][Full Text] [Related]
19. Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma.
Sand M; Hessam S; Amur S; Skrygan M; Bromba M; Stockfleth E; Gambichler T; Bechara FG
J Dermatol Sci; 2017 May; 86(2):142-148. PubMed ID: 28187958
[TBL] [Abstract][Full Text] [Related]
20. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma.
Liu R; Zhang H; Wang X; Zhou L; Li H; Deng T; Qu Y; Duan J; Bai M; Ge S; Ning T; Zhang L; Huang D; Ba Y
Oncotarget; 2015 Dec; 6(41):43831-42. PubMed ID: 26517093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
